n,n-dimethylarginine has been researched along with Cerebral Arteriosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bang, OY; Cho, YH; Chung, CS; Chung, JW; Kim, GM; Lee, KH; Moon, GJ; Oh, MJ | 1 |
| Alzamora, MT; Arenillas, JF; Barallat, J; Dávalos, A; Dorado, L; Galán, A; Hernández, M; Jiménez, M; López-Cancio, E; Massuet, A; Millán, M; Reverté, S; Suñol, A | 1 |
2 other study(ies) available for n,n-dimethylarginine and Cerebral Arteriosclerosis
| Article | Year |
|---|---|
Distinct Roles of Endothelial Dysfunction and Inflammation in Intracranial Atherosclerotic Stroke.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Aged; Arginine; Biomarkers; Endothelium; Female; Humans; Inflammation; Intracranial Arteriosclerosis; Male; Middle Aged; Stroke | 2017 |
Biological signatures of asymptomatic extra- and intracranial atherosclerosis: the Barcelona-AsIA (Asymptomatic Intracranial Atherosclerosis) study.
Topics: Aged; Arginine; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Cohort Studies; Cross-Sectional Studies; Diabetes Complications; Female; Humans; Insulin Resistance; Intracranial Arteriosclerosis; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Plasminogen Activator Inhibitor 1; Regression Analysis; Resistin; Risk Factors; Spain | 2012 |